AIM ImmunoTech Inc. HXB2.F Stock
AIM ImmunoTech Inc. Price Chart
AIM ImmunoTech Inc. HXB2.F Financial and Trading Overview
AIM ImmunoTech Inc. stock price | 0.33 EUR |
Previous Close | 0.4 EUR |
Open | 0.45 EUR |
Bid | 0.45 EUR x N/A |
Ask | 0.46 EUR x N/A |
Day's Range | 0.45 - 0.45 EUR |
52 Week Range | 0.24 - 0.82 EUR |
Volume | 45 EUR |
Avg. Volume | 0 EUR |
Market Cap | 23.81M EUR |
Beta (5Y Monthly) | -0.296126 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.55 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.67 EUR |
HXB2.F Valuation Measures
Enterprise Value | -10754215 EUR |
Trailing P/E | N/A |
Forward P/E | -1.3937501 |
PEG Ratio (5 yr expected) | -0.24 |
Price/Sales (ttm) | 151.66074 |
Price/Book (mrq) | 0.629055 |
Enterprise Value/Revenue | -68.498 |
Enterprise Value/EBITDA | 0.517 |
Trading Information
AIM ImmunoTech Inc. Stock Price History
Beta (5Y Monthly) | -0.296126 |
52-Week Change | -47.89% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.82 EUR |
52 Week Low | 0.24 EUR |
50-Day Moving Average | 0.4 EUR |
200-Day Moving Average | 0.47 EUR |
HXB2.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 48.41M |
Float | 47.5M |
Short Ratio | N/A |
% Held by Insiders | 1.88% |
% Held by Institutions | 11.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:44 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -13417.83% |
Gross Margin | 149.04% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -28.74% |
Return on Equity (ttm) | -43.68% |
Income Statement
Revenue (ttm) | 157K EUR |
Revenue Per Share (ttm) | 0.003 EUR |
Quarterly Revenue Growth (yoy) | 48.50% |
Gross Profit (ttm) | N/A |
EBITDA | -20792000 EUR |
Net Income Avi to Common (ttm) | -19286000 EUR |
Diluted EPS (ttm) | -0.35 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 30.85M EUR |
Total Cash Per Share (mrq) | 0.64 EUR |
Total Debt (mrq) | 814K EUR |
Total Debt/Equity (mrq) | 2.33 EUR |
Current Ratio (mrq) | 18.051 |
Book Value Per Share (mrq) | 0.709 |
Cash Flow Statement
Operating Cash Flow (ttm) | -17030000 EUR |
Levered Free Cash Flow (ttm) | -7850250 EUR |
Profile of AIM ImmunoTech Inc.
Country | Germany |
State | FL |
City | Ocala |
Address | 2117 SW Highway 484 |
ZIP | 34473 |
Phone | (352) 448-7797 |
Website | https://aimimmuno.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 22 |
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, prostate and pancreatic cancer, myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; Pharmaceutics International Inc.; Polysciences Inc.; and University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Q&A For AIM ImmunoTech Inc. Stock
What is a current HXB2.F stock price?
AIM ImmunoTech Inc. HXB2.F stock price today per share is 0.33 EUR.
How to purchase AIM ImmunoTech Inc. stock?
You can buy HXB2.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AIM ImmunoTech Inc.?
The stock symbol or ticker of AIM ImmunoTech Inc. is HXB2.F.
Which industry does the AIM ImmunoTech Inc. company belong to?
The AIM ImmunoTech Inc. industry is Biotechnology.
How many shares does AIM ImmunoTech Inc. have in circulation?
The max supply of AIM ImmunoTech Inc. shares is 56.25M.
What is AIM ImmunoTech Inc. Price to Earnings Ratio (PE Ratio)?
AIM ImmunoTech Inc. PE Ratio is now.
What was AIM ImmunoTech Inc. earnings per share over the trailing 12 months (TTM)?
AIM ImmunoTech Inc. EPS is -0.55 EUR over the trailing 12 months.
Which sector does the AIM ImmunoTech Inc. company belong to?
The AIM ImmunoTech Inc. sector is Healthcare.